-

CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of CVRx Inc. (“CVRx” or the “Company”) (NASDAQ:CVRX) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

[LEARN MORE ABOUT THE INVESTIGATION]

What Happened?

On April 7, 2025, CVRx announced weaker than expected preliminary first quarter results. In the Company’s earnings press release, CVRx’s President and Chief Executive Officer Kevin Hykes (“Hykes”) said that “many of [the Company’s] newer sales representatives are still in the early stages of development.” On this news, the price of CVRx shares declined by $5.34 per share, or approximately 46.3%, from $11.54 per share on April 7, 2025 to close at $6.20 on April 8, 2025.

Then, on May 8, 2025, CVRx announced weak first quarter results and lowered its full year revenue guidance. During the related earnings call, CEO Hykes said that recent salesforce changes at the Company were “more significant than initially anticipated and resulted in 25% of our current territory managers being hired between December and March.” On this news, the price of CVRx shares declined by $3.01 per share, or approximately 38.8%, from $7.78 per share on May 8, 2025 to close at $4.77 on May 9, 2025.

What Should I Do?

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.

If you purchased or otherwise acquired CVRx securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:CVRX

Release Versions

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

More News From Kirby McInerney LLP

CASH SHAREHOLDER ALERT: Pathward Financial, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Pathward Financial, Inc. (“Pathward” or the “Company”) (NASDAQ: CASH) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On July 22, 2026, Pathward reported fiscal third-quarter 2026. Among other things, the Company re...

REPL SHAREHOLDER ALERT: Replimune Group Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Replimune Group Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On July 28, 2026, the FDA released briefing documents regarding the Company’s lead trial for its dru...

PNR INVESTOR ALERT: Securities Class Action Filed Against Pentair plc – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Pentair plc (“Pentair” or the “Company”) (NYSE: PNR) common stock between April 28, 2026 and July 14, 2026, inclusive (“the Class Period”). If you suffered a loss on your Pentair investments, you have until October 2, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after this deadline. If...
Back to Newsroom